2nd International Conference on

Medical & Surgical Oncology

Theme: Recent development & advancements in Medical & Surgical Oncology

Event Date & Time

Event Location

Prague, Czech Republic

18 years of lifescience communication


Performers / Professionals From Around The Globe

Tracks & Key Topics

Medical Oncology 2019

About Conference

The European Committee welcomes you to attend the 2nd International Conference on Medical & Surgical Oncology focus on Current Advancements and its Applications in Immunology and Oncology from February 19-20, 2019 in Prague, Czech Republic the theme of this year’s meeting is “Recent development & advancements in Medical & Surgical Oncology" which will provide an international platform for discussion of present and future challenges in Oncology, Surgical Oncology education, continuing education and expertise meeting. World-leading health Immunologists, Oncologists, clinicians, educators and researchers will present cutting-edge and practical clinical techniques based upon widely accepted evidence and will introduce new and emerging research.

What’s New?

Medical Oncology 2019 includes international attendee workshops, lectures and symposia, including a designated registration area, a refreshment break and gala lunch. Immunologists & Oncologists can join the EuroSciCon as an international member to receive discounts on registration. So come and join leading experts and allied professionals from February 19-20, 2019 in Prague, Czech Republic to keep up with the rapidly accelerating pace of change that is already having an impact on the field of Cancer & Immuno Oncology and will continue to in the future.

The scientific program includes Keynote & Plenary talks, Video Presentations, Poster Presentations and E-Posters. Furthermore, oral communications of (post)doctoral junior scientists will be considered. It is the goal of the organizers to make this meeting an event of scientific excellence, attractive to both industrial and academic scientists in Medical Oncology & Surgical Oncology and its advancements.

EuroSciCon is the longest running independent life science events company with a predominantly academic client base. Our multi-professional and multi-speciality approach creates a unique experience that cannot be found with a specialist society or commercially.

Euroscicon are corporate members of the following organisations

  • Royal Society of Biology
  • IBMS
  • British Society for Immunology
  • Rare Care UK

Opportunities for Conference Attendees

For Researchers &Faculty:

  • Speaker Presentations
  • Poster Display
  • Symposium hosting
  • Workshop organizing

For Universities, Associations & Societies:

  • Association Partnering
  • Collaboration proposals
  • Academic Partnering
  • Group Participation

For Students & Research Scholars:

  • Poster Competition (Winner will get Best Poster Award)
  • Young Researcher Forum (YRF Award to the best presenter)
  • Student Attendee
  • Group Registrations

For Business Delegates:

  • Speaker Presentations
  • Symposium hosting
  • Book Launch event
  • Networking opportunities
  • Audience participation

For Companies:

  • Exhibitor and Vendor Booths
  • Sponsorships opportunities
  • Product launch
  • Workshop organizing
  • Scientific Partnering
  • Marketing and Networking with clients

Euroscicon organizes International Oncology Meetings annually across Europe, Austria, Ireland, Germany, France, Liechtenstein, Lithuania, Finland, Luxembourg, Hungary, Italy, Norway, Poland, Denmark, Macedonia, Greece, Portugal, Romania, Czech Republic, Switzerland, United Kingdom, Belgium, Scotland, Latvia, Ukraine, Sweden, Denmark, Spain, Netherlands, Russia, Bulgaria, France, with solitary subject of quickening logical revelations.


  • Antibody Therapy of Cancer
  • Anti-Cancer Drugs
  • Biochemistry of Cancer
  • Breast Cancer
  • Cancer Biomarkers
  • Cancer Cell Biology
  • Cancer Staging
  • Cancer Trends and Opportunities
  • Cardio-Oncology
  • Combining Cancer Immunotherapies
  • Endocrine and Neuroendocrine Tumors
  • Gastrointestinal Cancers
  • Head and neck cancers
  • Hematologic Cancers
  • Immuno Oncology
  • Immuno-Oncology Studies
  • Medical Oncology
  • Neuro Immunology
  • Neuro-oncology
  • Nuclear Medicine
  • Orbital and adnexal cancers
  • Radiation Oncology
  • Reproductive Cancer
  • Surgical Oncology
  • Tumour Immunotherapy Research
  • Types of Cancer


Track: Medical Oncology

It is the analysis of cancer with medicine, made up of chemotherapy, surgical oncology is the surgical aspects of cancer including biopsy, staging, and surgical resection of tumors, and radiation oncology is the analysis of cancer with therapeutic radiation. Medical Oncology is usually works in conjunction with Surgical Oncology or Radiation Oncology to give the best clinical outcomes. We determine the right treatment plan for each individual based on various factors as stage of cancer, extent of the damage, other medical conditions, and location within the body. These treatment plans contain any combination of the following: Chemotherapy, Radiation Therapy and Surgery.

Medical Oncology (MO) conveys the effects of clinical and test research in oncology and hematology, especially with trial therapeutics with the field of immunotherapy and chemotherapy. It additionally gives best in class surveys on clinical and test treatments in oncology and hematology.

  • Chemotherapy
  • Immunotherapy
  • Targeted therapy
  • Immunobiology
  • Pathogenesis

Track: Surgical Oncology

Surgical oncology is the branch of surgery applied to oncology and it focuses on the surgical management of tumors, especially cancerous tumors. There are currently 19 surgical oncology fellowship training programs in the United States that have been approved by the Society of Surgical Oncology and this number is expect to grow. The collaboration with radiation and medical oncologists on the use of neoadjuvant chemotherapy or radiotherapy to enhance or permit surgery possible and on the indications for adjuvant therapy after surgery. The technical side of surgery has also been transformed in the past few decades with advance techniques.

  • Transanal Endoscopic Microsurgery
  • Robotic surgery
  • Reconstructive surgery
  • Laparoscopic cancer surgery
  • Cytoreductive surgery with HIPEC
  • Sarcoma surgery

Track: Tumor Virology

Tumor virology deals with the specific virus infections and cancer, oncogenes, tumor suppressors, oncogenic cofactors, disruption of innate/ adaptive immune responses, latency, viral mimicry/piracy of cellular regulatory genes, genomic instability and role of non-coding RNAs in viral pathogenesis. The purpose of this study is to develop viral vectors for human cancer gene therapy and to progress vaccine strategies for treatment of viral-associated cancers. Several methods are being trailed including genetic immunization with recombinant viral vectors based on Semliki Forest virus, immune checkpoint inhibitors and strategies to re-modulate the immunosuppressive tumor environment.

  • Viral Mimicry of genes
  • Principle investigator
  • Viral Therapy
  • Viral-associated Cancers

Track: Cancer: Alternative Medicine

The alternative medicine for cancer is something which is given for the cancer patients as an alternate to the existing therapies, which are not proved by the Food and Drug Administration - FDA. The Massage therapy have showed some good results but they are only temporary. Other therapies like supportive psychotherapy and hypnosis shows very weak results. The Cognitive therapy showed moderate benefits but again it is also temporary. The suggestion for Music therapy is ambiguous, and certain herbal interferences are very poisonous to some cancer patients. The Acupuncture Treatment is also being predominantly used alternative treatments, but with very weak results. All these treatments will give only placebo effects, nothing more than that for cancer therapy. Cancer Science Conferences helps to analyses the concurrent ways in cancer therapy.

  • Gerson therapy
  • Acupuncture
  • Integrative Medicine
  • Dietary Supplements and Herbal Remedies
  • Biologic Treatments
  • Meditation & Yoga

 Track: Clinical Trials in Medical Oncology

Clinical trials look at new cancer medicines through patient-based research. They give the basic information to decide whether new medications are protected and powerful. An extensive variety of treatments are contemplated in clinical trials going from drugs through to radiological and careful techniques, and additionally precaution alternatives to prevent cancer. Clinical trials are fundamental for the progression of oncological learning and the change in quality of life for cancer patients. The Medical Oncology Group of Australia is focused on supporting clinical trials.

  • Oesophagal & Breast Cancer Clinical Trials
  • Lung Cancer Clinical Trials
  • Ovarian & Liver Cancer Clinical Trials
  • Bladder Cancer & Prostate Cancer Clinical Trials
  • Blood & colon Cancer Clinical Trials
  • Cancer Clinical Trials Data Management

Track: Cancer Therapeutics and Novel Approaches

In cancer treatment the already existing treatments are severely related to many side effects and are highly poisonous, which will reduce the quality of life. This incorporates the discovery of novel approaches in cancer treatment. The most important approach is the cancer immunotherapy, in which the activation of immune system happens for the treatment of cancer. Traditionally the Cytokine therapy is considered as a backbone of immunotherapy for cancer. The vaccines like peptide vaccines, tumor cell vaccines, immune cell vaccines, cancer vaccines are considered as a novelist finding in cancer field. In hematologic malignancy the adoptive cell therapy is deliberated as a new practice for cancer therapy. The molecular cancer therapy is reflected as a novel approach in cancer treatment. Tumor Immunology plays an important role in verdict of new approaches for cancer therapeutics. Cancer Conferences expresses its effort to combat cancer.

  • Cancer Epigenetics
  • Molecular Profiling Techniques
  • New Biologics & Vaccines
  • Chemical Proteomics
  • Combination Strategies in Immuno-oncology
  • Novel Biomarker Discovery

Track: Haematologic- Oncology

Hematologic Oncology is the branch of medicine study about the diagnosis ,prevention, treatment, and avoidance of disease identified with blood. Hematology incorporates the study of etiologist includes treating disease that influence the production of blood and its parts, for example, platelets, hemoglobin, blood proteins, bone marrow, platelets, veins, spleen, and the component of coagulation. The research facility work that goes into the study of blood is much of the time performed by a medical technologist or therapeutic lab researcher. Hematologists also conduct study in oncology and work with oncologists, individuals who may specialize just in that field rather than both-the therapeutic treatment of tumor. There are different disorders that people are influenced by hematology. A couple of these different type of blood conditions that are looked at incorporate anaemia, hemophilia, general blood clots, bleeding disorders, and so forth. With respect to related blood diseases, for example, leukemia, myeloma, and lymphoma, these are more serious cases that should be analysed.

  • Myeloma
  • Myelodysplastic Syndromes
  • Multiple Myeloma
  • Leukaemias
  • Lymphoma

Track: Biomarkers

Protein Biomarkers can be used as biomarkers for early recognition of cancer particularly used for the identification of breast cancer. Diagnostic Patients with suspected pancreatic cancer will experience an underlying CT scan to decide if a suspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-respectable stage III and IV disease and a biopsy will be attempted to confirm pancreatic tumour by H&E pathological assay. The presence of cancerous cells by means of pathology is very challenging because of high quantities of non-cancerous stromal infiltrating cells and administration of chemotherapy or enrolment into a clinical trial will just initiate on definitive diagnosis of pancreatic cancer. These will see particularly stains neoplastic pancreatic cells would empower the pathologist to confidently diagnose pancreatic cancer and in this way offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 has been recognized as a highly sensitive (98%) and particular (95%) IHC marker for pancreatic cancer and CRT is looking for a partner to build up an IHC based test to distinguish BI-010 in fine needle suction biopsies from biopsy tests.

  • Molecular Biomarkers
  • Immuno-Oncology Biomarkers
  • Biomarkers in patient selection
  • Clinical and Translational Biomarkers
  • Biomarkers in Drug Discovery & Development: by Therapeutic Areas
  • Neurological Biomarkers
  • Immunological Biomarkers
  • Cardiovascular Biomarkers
  • Regulatory and Reimbursement Issues in Biomarkers
  • Biomarkers in Personalized Medicine
  • Imaging Biomarkers
  • Biomarker Discovery & Validation
  • Emerging Therapeutic Biomarkers
  • Exosomes
  • Genetic-based Biomarkers and Next-Generation Sequencing (NGS)
  • Digital Biomarkers

Track : Neonatal & Pediatric Oncology

Neonatal & Pediatric Oncology is the term used to comprise all malignant conditions among neonates & children with cancer. The most common childhood cancers are leukemia (begins in blood-forming tissue such as bone marrow), lymphoma (cancer in the cells of immune system), neuroblastoma (nerve cells), retinoblastoma (occurs in the tissues of the retina), Wilms tumor (kidney cancer), and brain tumors, such as gliomas. Childhood cancers are very rare and may differ from adult cancers in the way they grow, spread, treated, and respond to treatment.

  • Pediatric Oncology Nursing
  • Psychosocial Aspects of Pediatric Oncology
  • Integrative Pediatric Oncology
  • Palliative Care in Pediatric Oncology
  • Pioneers in pediatric oncology
  • Supportive Care in Pediatric Oncology
  • Fetal and Neonatal Pathology
  • Neonatal Tumors
  • Radiological Imaging of the Neonate

Track: Nanotechnology in Cancer Treatments

Nanotechnology is rapidly developing a technology subdivision that affects many fields. Nanoscale devices are one hundred to ten thousand times smaller than human cells. They are similar in size to large biological molecules, such as enzymes and receptors. Due to their small size, nanoscale devices can easily interact with biomolecules both on the surface and inside cells. Medicine is also affected by nanotechnology; since, in the treatment of cancer, nanotechnologically modified methods can be used. One of the fields of use in the development of nanotechnology is the treatment of cancer.

Nanotechnology can help to have a better diagnosis with less harmful substances such as optical nanoparticles. A subdivision of technology that is nanotechnology will play an important role. Nanotechnology can provide rapid and sensitive detection of cancer cells, more effective administration of drugs to tumor cells, a molecularly targeted cancer therapy and highly effective therapeutic agents.

  • Challenges of focused nano particles for malignancy treatment
  • Types of nanoparticles utilized as a part of malignancy treatment
  • Dendrimer and carbon nanotube
  • Nanoparticles and its toxic effects

Track: Cancer Epidemiology, Screening, Diagnosis & Prognosis

The Epidemiology of Cancer is the study of the factors affecting Cancer, a way to conclude possible tendencies and causes. The study of Cancer Epidemiology practices Epidemiological Methods to discover the cause of Cancer and to recognize and develop enhanced treatments. This extent of study must cope with difficulties of lead time bias and length time bias. Lead time bias is the theory that primary diagnosis may artificially inflate the survival statistics of a Cancer, without actually improving the natural history of the disease. Length bias is the concept that tender growing, more lethargic Tumors are more likely to be recognised by Screening Tests, but improvements in diagnosing more cases of indolent Cancer may not translate into better patient outcomes after the implementation of Screening Programs.

Most Cancers are originally known either because of the appearance of signs or symptoms or through Screening. Neither of these leads to a Definitive Diagnosis, which comprises the examination of a tissue sample by a pathologist. People with suspected Cancer are observed with medical tests. These generally include Blood Tests, CT Scans, X-rays and Endoscopy.

Screenings can find initial Cancer, when it’s most curable. Cancer Screening aims to identify Cancer before symptoms appear. This may include blood tests, urine tests, other tests, or Medical Imaging. The aids of screening in terms of Cancer Prevention, early detection and subsequent treatment must be weighed beside any harm. Worldwide screening, Population Screening or Mass Screening involves screening everyone, generally within a definite age group. Selective Screening detects people who are known to be at advanced risk of developing Cancer, such as people with a family history of Cancer.

  • Circulating tumor cells (CTCs) towards cancer Diagnosis
  • Microfluidic device for cancer screening
  • Cancer Staging
  • Early detection and diagnosis of Cancer
  • Early detection and diagnosis of Cancer

Track: Cancer Preventive Vaccines: Oncolytic Therapy & Others

Cancer vaccines stimulate the immune system’s capability to protect the body against the infectious agents that may cause disease. Cancer vaccine is also known as biological response modifiers. There are two types of cancer vaccine: Preventive vaccine and treatment vaccine. The Preventive vaccine is used to stop the development of the Cancer cell and treatment vaccines are used to treat the existing cancer by natural immune system to fight against the cancer.

Oncolytic Virus is a virus that infects and breakdown Cancer cells but not normal cells. Oncolytic virus therapy may make it easier to kill tumor cells with chemotherapy and radiation therapy. It is a type of targeted therapy. Also called oncolytic virotherapy, viral therapy, and virotherapy.

  • Human papillomavirus (HPV) vaccine
  • Hepatitis B virus (HBV) vaccine

Track: Precision Medicine and Immuno-Oncology

Precision medicine or personalized medicine is an approach to individual care for selecting treatment that are helpful to the patients based on a genetic understanding of their disease. Depending upon the type of cancer, its size and proliferation, combination of Treatment surgery, Chemotherapy, Radiation therapy and Immunotherapy may vary. But in precision medicine, information about genetic changes in the tumor can be helping to decide the Treatment.

Cancer Immunology is concerned with Immune system in progression and development of Cancer. The most well-known application is Cancer Immunotherapy where the immune system is used to treat cancer.

  • Novel concepts in Bi-specific Antibodies Engineering
  • Pre-clinical and Translational Immuno-Oncology Developments
  • Personalized Immunotherapy, Combination Immunotherapy and Viral Therapies

Track: Cancer Cell Biology

Cancer cells have the capacity to divide in an uncontrollable manner. Cancer cells ignore signals that will be active in stopping the cell division, apoptosis and cell shedding. In a cancer cell, most of the genes metamorphose into a defective one. Cancerous tumors can spread into, or invade, nearby tissues so they are the cause of malignancy. By the progression of these tumors, some cancer cells can be fragmented and travel to other parts in the body through the plasma or the lymphatic system and forms another tumor cell far away from the original tumor which is called metastasis. Cancer pathogenesis deals with the molecular, biochemical, and cell-based approaches are included in cancer cell biology to better understand. Cancer Genetics deals with the cancer growth due to genetic changes, if the changes are present in germ cells it can be inherited from parents to off- springs. Tumor Immunology plays an important role in decision of new approaches for cancer therapeutics.

  • Oncogenes
  • Tumour Immunology
  • Tumour Biology
  • Tumour Progression
  • Carcinogenesis & Mutagenesis
  • Tumour Cell Interactions
  • Cancer Cell Pathology

Track: Organ-Defined Cancers

Cancer has a differentiated nature in association to the organ specificity. All type of cancer has its distinctive characters; the basic processes that causes cancer are similar in all forms cancers. Based on the cancer location in the body organ, it is named as Organ Specific Cancers. The various types of cancers include Breast Cancer, Bone Cancers, Ovarian Cancer, Prostrate Cancer, Neck Cancer, Lung cancer, Head cancer, skin cancer, Bile duct cancer, anal cancer etc. The tumor burden progressively hinders with regular biochemical functions carried out by the host organs. Based on the differences in the cancer cells while they grow led to the development of the drug that targets the specific area, which is called Targeted Cancer Therapy. Targeted therapy will not act like Chemotherapy, affecting the parts that are not targeted. The stem cell therapy also provides virtuous way for treating cancer.

  • Head & Neck Cancer
  • Bone Cancer
  • Skin Cancer
  • Lung Cancer
  • Blood Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Brain Cancer
  • Pancreatic Cancer
  • Thyroid Cancer
  • Kidney Cancer

Track: Cancer Metastasis

The spread of cancer from one part of the body to another part or to lymph nodes, which are not directly connected to each other is called cancer metastasis. Cancer is considered as a deadly disease mainly because of its ability to spread in the body. This metastasis takes place through the blood stream or the lymph system. The most common metastasis parts of the body are the lungs, bones, liver and brain. The metastatic cancer cells does not resemble the feature of the cells where it was found but it resembles the primary cancer cells i.e. it was considered as a next stage of the primary cancer cells. All metastatic cancers are considered as advanced cancers. The cancer survival and treatment is influenced by whether the cancer cells are localized or spreads to other parts. When the cancer starts to spread it is very difficult to control. Even if the treatment is continued, it will be only palliative care. The pain killing will be mostly by Anti-cancer drugs i.e. chemotherapy. Cancer Management is a multidisciplinary approach that deals with the various type of cancer complications and its preventive measures. Cancer Conferences is an important key for both educational and clinical guidance for managing cancer patients.

  • Metastatic Symptoms
  • Pathophysiology
  • Organ-Specific Targets
  • Diagnosis & Management
  • Multimodal Therapies

Track: Cancer Diagnosis and Screening

Screening tests can help to find cancer at an early stage, before recognizing the symptoms. Diagnostic testing of cancer includes the tests done by a pathologist to confirm the stage of cancer, size of the tumor, area infected by the tumor, etc.  Various pathological and histopathological techniques are used in cancer diagnosis. Some of the common procedures for Cancer diagnosis are biopsy, MRI, X-Ray etc. Some of the other techniques which are commonly used nowadays to detect or identify the cancers originating from an organ are endoscopy for gastrointestinal cancers, mammography for breast cancers etc. One of the newly invented techniques for detection of organ defined cancers is nuclear medicine imaging which utilizes radiopharmaceuticals to identify the structure of the tumor present in that specified organ or tissue. Cancer Conferences provides a podium to bring forward the novel therapies for cancer.

  • Sigmoidoscopy
  • Colonoscopy
  • Nuclear imaging
  • Screening test
  • Benefits of screening
  • Angiogenesis Inhibitors
  • Synthetic Lethality
  • Risks of screening
  • Molecular Diagnostics

Track: Cancer Therapy

Cancer can be treated by different methods. The treatment depends on the location, Stage and grade of the cancer. Bone Marrow transplantation is a therapy that takes place in case of leukemia lymphoma and myeloma. In Radiation therapy, the patient is treated with the ionization radiations which destroys the cancer cells. Chemotherapy, in which anti-cancer drugs are used to treat the cancer. Cancer Immunotherapy is a type of treatment in which the immune system is trigged to treat the cancer. Some cancers will be sensitive to hormones so by inhibiting or removing the specific hormones, the cancer growth can be controlled, it can be called as Hormone Therapy. The metastatic cancers can be best treated with Targeted therapy, in which the location of cancer can be targeted easily. Many novel Approaches to Cancer Therapeutics are being exposed in the cancer science and therapy field. Cancer Science and Therapy Conferences are an endeavor to procure mastery in cancer research field.

  • Gene Therapy
  • Molecular Targeted Therapies
  • Hormone Replacement Therapy
  • Bone Marrow Transplantation
  • Chemotherapy
  • Radiation Therapy
  • Biomarkers in cancer detection
  • Immunotherapy

Track: Cancer: Mode of Existence

Around 330,000 people are analyzed with cancer each year and 161,000 will die, according to statistics from Cancer Research UK. Cancer is caused by both internal factors (such as hormones, inherited mutations and immune conditions) and environmental factors. The important lifestyle factors include alcohol, tobacco, diet, obesity, infectious agents, environmental pollutants, and radiation increase the mortality of cancer. Tobacco use increases the threat of developing at least 14 types of cancer. The chronic alcohol consumption is a risk factor for cancers of the upper aero digestive tract, including cancers of the oral cavity, pharynx, hypopharynx, larynx, and esophagus. Numerous air pollutants such as PAHs (polycyclic aromatic hydrocarbons) increase the risk of lung cancer. Some cancer cases may be persuaded by ultraviolet (UV), pulsed electromagnetic fields and radiation. Diet is linked to cancer deaths in colorectal cancer cases. The lesser hereditary impact of cancer and the modifiable nature of the environmental factors direct to the preventability of cancer

  • Alcohol and Tobacco
  • Diet and Obesity
  • Environmental pollutants
  • Radiation
  • Magnetic Resonance Imaging
  • Endoscopic Ultrasound
  • Tumor Molecular Profiling
  • X-Ray
  • Nuclear Medicine Imaging

Track: Artificial Intelligence and its scope in Cancer therapy

Artificial Intelligence in the treatment of cancer could be a break-through globally in the field of cancer. When cancer is detected at an early stage, treatment is more likely to be successful. But too often, cancers are diagnosed at a later stage when they are much harder to treat. There are many reasons for this, including that the symptoms people experience could be vague and linked to much less serious conditions. Detecting cancer earlier by interrogating medical and non-medical data sets using machine and deep-learning is a possible solution to prevent cancer or at the least, identify cancer at an early stage.

  • Gerson therapy
  • Acupuncture
  • Integrative Medicine
  • Dietary Supplements and Herbal Remedies
  • Biologic Treatments

Market Analysis

Worldwide Cancer Diagnostics advertise is relied upon to develop from $8.54 billion out of 2016 to reach $22.41 billion by 2023 with a CAGR of 8 %. Expanding frequency of cancer illnesses, developing mindfulness about human services, and later mechanical progressions in symptomatic gadgets are a portion of the elements moving the market development. Moreover, ideal government repayment approaches, expanding interests in innovative work exercises are some different elements boosting the market development amid the estimated time frame.

Then again, high expenses of analytic gadgets, strict controls for new item endorsements are the variables restricting the market development. Just 10% of patients determined to have a harmful neoplasm get by for over five years. Colorectal cancer (of the colon and rectum), the most widely recognized threatening tumor in the event that we amass people together, presents a normal survival rate of 50-55% five years after analysis, implying that a large portion of the patients survives this type of cancer. Prostate cancer, today the most widely recognized tumor in men, has an inexorably great prognosis, with a worldwide survival rate of 76%, which is higher in youthful grown-ups. Ovarian cancer displays an exceptionally shifted prognosis relying upon age: while 70% of the gathering somewhere in the range of 15 and 44 years survives this type of cancer, this is the situation for just 19% of those more than 74 years of age. Consistently omics arranges cancer gatherings in Europe.

Cancer Survivors Market analysis     

For the result of legislative FA, an expanded Cox relapse display was connected to the entire companion, with age at growth conclusion as the timeâ€Âdependent variable, yielding risk proportions (HRs) with 95% certainty interims (CIs). This strategy was decided to completely exploit the forthcoming idea of the information and to represent the adjustments in risk rates over the span of followâ€Âup. The followâ€Âup for this investigation began at age 18 years (guardians are obliged by law to maintain their youngsters until that age) and finished at the date of the principal event an individual got FA, blue-penciling at the date of death, resettlement, or December 31, 2007, whichever happened first.

Cancer survivors were additionally classified into significant cancer gatherings (leukemia, lymphoma, focal sensory system [CNS] tumors, testicular tumors, dangerous melanoma, bone, and delicate tissue sarcomas, cancers of the female genital tract [cervix/uterus/ovarian], and "other"). Survivors likewise were arranged into CCS and AYAs. Examinations was being balanced for a year of birth and for parental instruction(the most elevated training accomplished by the two guardians)separated into 3 classifications—bring down training (<11 years), middle of the road instruction and tertiary training (>14 years) to represent contrasts in family financial status as a conceivable confounder.27 Marital status was incorporated as an arbiter in early investigations yet was excluded in the last model, in light of the fact that the appraisals delivered were comparative, and modifying for this variable could have presented colliderâ stratification inclination.

  • A natural innovation of cancer prevention
  • Therapies for diagnosing the cancer hematology
  • Oncologists
  • Radiologists
  • Pathologists
  • Haematologists
  • Gynecologists
  • Chemotherapists
  • Academicians
  • Research Scholars
  • Student Delegates from Academia

Major cancer associations across the globe

  • American Association for cancer research
  • American Neuroma Association
  • Cancer Research Institute
  • Irish Cancer Society
  • National Cancer Society of Malaysia
  • National Cancer Institute
  • Cancer Research UK
  • Association of Oncology Social work
  • The Association for Cancer Surgery (BASO)
  • Global Initiative Against HPV and Cervical Cancer       
  • Global Lung Cancer Coalition (GLCC)
  • International Gynecologic Cancer Society
  • Cancer Council Australia
  • Australian Cancer Research Foundation
  • Australian Cancer Foundation
  • Prostate Cancer Foundation of Australia
  • National Breast Cancer Foundation
  • Lung Foundation Australia
  • Kids with Cancer Foundation
  • Australian Cervical Cancer Foundation
  • Cure Cancer Australia Foundation
  • Clinical Oncology Society of Australia
  • Ovarian Cancer Australia
  • Children’s Cancer Foundation
  • Australian Gynaecological Cancer Foundation
  • Cure Brain Cancer Foundation

Top universities related to cancer

  • University of South Australia
  • University of Chicago Medicine  Cancer Centre
  • Japanese Foundation for Cancer Research
  • Shizuoka Cancer Centre/Research Institute
  • Rajiv Gandhi Cancer Institute & Research Centre
  • UCL Cancer Institute
  • Bart’s Cancer Institute – Queen Mary University
  • Peter McCollum Cancer Centre
  • QIMR Berghofer Medical Research Institute
  • Stanford Cancer Institute – Stanford University
  • MD Anderson Cancer Centre
  • National Cancer Centre
  • Tsukuba University Hospital
  • Kanazawa University | Cancer Research Institute
  • Mitchell Cancer Institute

Pharmaceutical Companies Related to Cancer:

  • Roche pharmaceutical
  • Celgene pharmaceuticals
  • Johnson and Johnson pharmaceutical
  • Pfizer Pharmaceuticals
  • Bristol Myers Squibb pharmaceuticals
  • Novartis Pharmaceuticals
  • AstraZeneca Pharmaceuticals
  • Merck & co pharmaceuticals
  • Abbvie pharmaceuticals
  • Eli Lilly Pharmaceuticals



Past Conference Report

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Immuno-Oncology – 2018 Conference the successful!
1st Edition of World congress on Immuno-Oncology – 2018, hosted by the Euroscicon Ltd. was held during July 23-24, 2018 at HYATT PLACE, Amsterdam, Netherlands based on the theme “The Current Advancements in Cancer science-2018 " which got magnificent response. With the support and guidance of Organizing Committee Members and Editorial Board Members and astonish presentations of all participants along with Scientists, Researchers, Students and leaders from various fields of Oncology made this event a grand success. 
Euroscicon Ltd expresses its gratitude to the conference Moderator, namely Dr. Mohamed Mostafa Rizk, University of Alexandria, Egypt for taking up the responsibility to coordinate during the sessions for smooth functioning of this event. We are indebted to your support. A very special thanks to our Exhibitors and Sponsors to have bestowed and their faith and invested in us to make this event a fruitful one. We hope you continue your support in our future endeavours. The conference was initiated with the Honourable presence of the Keynote forum. The speakers list includes: 
  • Dr. Weisi Yan, University of South Alabama, USA
  • Dr. Donglu Shi, University of Cincinnati, USA
  • Dr. Igor Smit, Ijsselland Ziekenhuis, Netherlands
  • Dr. Kenji Ohe, Fukuoka University, Japan
  • Dr. Dwayne N. Jackson, University of Western Ontario, Canada
  • Dr. Mohamed Mostafa Rizk, University of Alexandria, Egypt
  • Dr. Jiangwen Zhang, University of Hong Kong, Hong Kong
  • Dr. María del Rosario Davalos Gamboa, University of San Simon, Bolivia
  • Dr. Jose Antonio Matute Briceno, Sonora Cancer Research Center-Cics USA, Mexico
  • Dr. Wassil Nowicky, Ukrainian Anti-Cancer Institute, Austria
  • Dr. Mohammed Y Almaghrabi, Jing Abdullah Medical City, Kingdom of Saudi Arabia
  • Dr. Jan Jacques Michiels, Goodheart Institute and Foundation in Nature Medicine & Health, Netherlands
  • Dr. Kamlesh Guleria, Guru Nanak Dev University, India
  • Dr. Adnan Yousif Rojeab, London College UCK, U.K
  • Dr. Marjan Jalalimehr, Razi institute, Iran
  • Dr. George Kunudji, Bikbok Herbal Centre, Ghana
  • Dr. Jana Slobodníkova, Alexander Dubcek University of Trencin, Slovakia
  • Dr. Dina Ron, Israel Institute of Technology, Israel
The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:
  • Immuno-Oncology Studies
  • Oncology
  • Clinical Oncology
  • Tumor Immunology
  • Types Of Cancer
  • Cancer Research & Cancer Vaccines
  • Antibody Therapy Of Cancer
  • Combining Cancer Immunotherapies
  • Immune Checkpoint Inhibitors
  • Radiology And Imaging In Cancer
  • Cancer Prognosis & Diagnosis
  • Cancer Micro And Immuno Environment
  • Stem Cell Therapy
  • Biomarker And Drug Targeting
  • Cancer Pharmacology
  • Cancer Biomarkers
  • Cancer Genomics And Metabolomics
  • Immuno-Oncology Studies
  • Cancer & HIV
  • Neuro Immunology
  • Tumor Immuno Therapy Research
  • Radiation Oncology
Euroscicon Ltd also took the privilege of felicitating and Immuno-Oncology– 2018 Organizing Committee, Editorial Board Members of Archives in Cancer Research, Keynote Speakers, Chair and Co-Chairs, Moderator and Exhibitor who supported this event. With the grand success of Cancer Science – 2018, Euroscicon Ltd is proud to announce the “International conference on Medical & Surgical Oncology" to be held during February 19-20, 2019 at Prague, Czech Republic.

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker


A huge thanks to all our amazing partners. We couldn’t have a conference without you!